Meeting
2011 ASCO Annual Meeting
Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors.
Authors
F. L. Day
Peter MacCallum Cancer Centre, Melbourne, Australia
F. L. Day , J. Karnon , D. Rischin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Supportive Care
Citation
J Clin Oncol 29: 2011 (suppl; abstr 9054)
Abstract #
9054
Poster Bd #
43E
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Hepatitis B virus screening before adjuvant chemotherapy in patients with early stage breast cancer: A cost-effectiveness analysis.
First Author: William W. L. Wong
Poster
2016 ASCO Quality Care Symposium
Hepatitis B reactivation in patients with solid tumors: A systematic review and meta-analysis.
First Author: Lisa K. Hicks
Poster
2016 ASCO Quality Care Symposium
Improving screening and prophylaxis of Hepatitis B in immunosuppressed patients.
First Author: Mary Mitsuko Ichiuji
Poster
2013 ASCO Annual Meeting
Hepatotoxicity with chemotherapy in patients infected with hepatitis B virus.
First Author: Jean-Luc Szpakowski